The development of new biopharmaceutical products begins with Chemistry, Manufacturing, and Controls (CMC). The CMC process is crucial for scaling a drug from laboratory bench studies to clinical trials and beyond. Documenting each step along the way ensures that your drug products, substance or formulation will meet regulatory compliance and obtain market approval from bodies like the FDA, EMA, and other global regulatory agencies.
Regulatory support for Chemistry, Manufacturing, and Controls (CMC) is indeed crucial for the successful development and commercialisation of biopharmaceutical products. Proper regulatory oversight helps ensure that biopharmaceutical products are safe and effective for patient use.